Stockscreener 앱 받기
14.55
5.58%
-0.86
시간 외 거래:
14.56
0.010
+0.07%
전일 마감가:
$15.41
열려 있는:
$15.41
하루 거래량:
104.52K
Relative Volume:
0.59
시가총액:
$531.04M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+2.83%
1개월 성능:
+15.29%
6개월 성능:
-9.80%
1년 성능:
-21.61%
1일 변동 폭
$14.55
$16.00
1주일 범위
$13.62
$16.00
52주 변동 폭
$7.13
$29.74
Rapport Therapeutics Inc Stock (RAPP) Company Profile
명칭
Rapport Therapeutics Inc
전화
857-321-8020
주소
99 HIGH STREET, BOSTON
RAPP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RAPP
Rapport Therapeutics Inc
|
14.55 | 533.23M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Rapport Therapeutics Inc Stock (RAPP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 개시 | H.C. Wainwright | Buy |
| 2025-04-08 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-07-02 | 개시 | Jefferies | Buy |
| 2024-07-02 | 개시 | Stifel | Buy |
| 2024-07-02 | 개시 | TD Cowen | Buy |
Rapport Therapeutics Inc 주식(RAPP)의 최신 뉴스
Can Rapport Therapeutics Inc. hit a new high this monthLong-Term Trend Tracking and Signal Summary - Newser
What momentum shifts mean for Rapport Therapeutics Inc.Portfolio Building Plan and Summary Guide - Newser
Rapport Therapeutics Inc.’s volatility index tracking explainedMarket Downturn Defense Strategy Analysis - Newser
Chart based exit strategy for Rapport Therapeutics Inc.Expert-Backed High Yield Stock Watchlist - Newser
Published on: 2025-08-10 00:05:31 - Newser
Market reaction to Rapport Therapeutics Inc.’s recent newsSmart Stock Forecast Using AI Algorithms - Newser
Candlestick signals on Rapport Therapeutics Inc. stock todayReal Time Trade Execution Alert Plan - Newser
Chart overlay techniques for tracking Rapport Therapeutics Inc.Short-Term Growth Watch with Signal Prediction - Newser
Comparing Rapport Therapeutics Inc. in custom built stock radarsFree Risk-Adjusted Picks With Exit Strategy - Newser
What is HC Wainwright’s Estimate for RAPP Q2 Earnings? - Defense World
Will Rapport Therapeutics Inc. rebound enough to break evenFree Risk Adjusted Technical Entry Plan - Newser
Rapport Therapeutics (NASDAQ:RAPP) Coverage Initiated at HC Wainwright - Defense World
Rapport Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Rapport Therapeutics' Q2 2025 Update: RAP-219's Precision Neuroscience Potential and September 2025 Catalyst - AInvest
Rapport (RAPP) Q2 Net Loss Widens 47% - Nasdaq
Rapport Therapeutics reports Q2 EPS (75c), consensus (79c) - TipRanks
Rapport Therapeutics sees cash runway through end of 2026 - TipRanks
Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update - GlobeNewswire
Press Release: Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update - 富途牛牛
Rapport Therapeutics (RAPP) Expected to Announce Earnings on Thursday - Defense World
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga
HC Wainwright Initiates Rapport Therapeutics at Buy With $31 Price Target - MarketScreener
Is Rapport Therapeutics Inc. Stock a Smart Buy in 2025 Investment Analysis InsideFree Community Entry Consensus Trade Ideas - Newser
Bank of New York Mellon Corp Acquires 15,514 Shares of Rapport Therapeutics, Inc. (NASDAQ:RAPP) - Defense World
How hedge fund analytics apply to Rapport Therapeutics Inc. stockFast Entry Strategy with Price Prediction - Newser
Applying chart zones and confluence areas to Rapport Therapeutics Inc.Free Trade Setups With Clear Risk Limits - Newser
Rapport Therapeutics Inc expected to post a loss of 83 cents a shareEarnings Preview - TradingView
AI Indicators Detect Buy Opportunity in Rapport Therapeutics Inc.Community Verified Stock Suggestions Drive Volume - metal.it
Is Rapport Therapeutics Inc. a good long term investmentFree Advanced Stock Screener Access - Jammu Links News
What institutional investors are buying Rapport Therapeutics Inc. stockUnlock expert insights for smarter investing - Jammu Links News
Is Rapport Therapeutics Inc. a growth stock or a value stockConsistently superior profits - Jammu Links News
Does Rapport Therapeutics Inc. stock perform well during market downturnsUnmatched market performance - Jammu Links News
How does Rapport Therapeutics Inc. generate profit in a changing economyAchieve rapid portfolio growth with expert help - Jammu Links News
What drives Rapport Therapeutics Inc. stock priceMassive wealth growth - Jammu Links News
How Rapport Therapeutics Inc. stock performs during market volatilityAlpha Stock Picks with Chart Confirmation - Newser
What is the dividend policy of Rapport Therapeutics Inc. stockRapid market gains - Jammu Links News
Is Rapport Therapeutics Inc. stock overvalued or undervaluedSuperior profit margins - Jammu Links News
Is it the right time to buy Rapport Therapeutics Inc. stockFree Stock Market Query - jammulinksnews.com
What is the risk reward ratio of investing in Rapport Therapeutics Inc. stockExceptional portfolio growth - Jammu Links News
What are Rapport Therapeutics Inc. company’s key revenue driversAccess high-yield investment alerts now - Jammu Links News
How strong is Rapport Therapeutics Inc. company’s balance sheetGet daily updates on promising stocks - Jammu Links News
Is now a turning point for Rapport Therapeutics Inc.Daily Stock Watch Summary with Key Insights - Newser
Rapport Therapeutics Inc (RAPP) 재무 분석
Rapport Therapeutics Inc (RAPP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):